How will Depo-Provera settlement payments be made?

Short answer: Through a court-supervised process: registration by November 30, 2026, review by a court-appointed settlement administrator, a qualified settlement fund established October 29, 2026, and resolution of medical liens. The parties told the court they expect payments to begin rolling out in the first quarter of 2027.

The process, step by step

  1. Registration. Claimants must register for the Settlement Program by November 30, 2026, and counsel submits the registrations.
  2. Claims review. A settlement administrator, appointed on August 5, 2026, processes claims and identifies to the court anyone who is ineligible.
  3. The fund. On October 29, 2026 the court established the qualified settlement fund that holds the settlement money, along with a separate common benefit fund for shared litigation costs.
  4. Liens. A lien resolution master, appointed on September 4, 2026, works out what health insurers or government programs that paid for treatment must be repaid from awards.
  5. Supplemental fund. A supplemental compensation fund allocation master was appointed the same day to allocate a separate supplemental fund.
  6. Payments. The parties expect payments to begin in the first quarter of 2027. That is the parties’ expectation reported to the court, not a court deadline.
Timeline of the Depo-Provera litigation from the March 2024 BMJ study to the November 30, 2026 settlement registration deadline and expected 2027 payments
Key dates in the Depo-Provera meningioma litigation. Sources: The BMJ; JPML; FDA; Case Management Orders 12 and 14.

What is not public

The Master Settlement Agreement is confidential, so the allocation criteria and any individual amounts have not been published. Figures you may see online come from third parties, not from the court or the parties, and we do not repeat them.

SourcesN.D. Fla. CMO 1410 Aug 2026N.D. Fla. CMO 135 Aug 2026N.D. Fla. QSF order29 Oct 2026N.D. Fla. CMO 174 Sep 2026N.D. Fla. CMO 154 Sep 2026N.D. Fla. CMO 1227 Jul 2026

Checked against the court record and primary sources on November 12, 2026 by Mason Arnao. This is general information, not legal advice. Related: What compensation is available?.

Settlement registration closes November 30, 2026

The court set November 30, 2026 as the deadline to register for the Depo-Provera Settlement Program. If you already hired a lawyer, ask today whether you are registered. New claims can still be filed, but they proceed as ongoing litigation, and state filing deadlines keep running. Read Case Management Order No. 14

Free · Confidential · No obligation

Free Depo-Provera Case Review

Tell us what happened and a trained case advisor will review it. You choose whether you want to be contacted.

  1. 1
    Share the basicsYour use, your diagnosis and your state.
  2. 2
    A case advisor reviews itAgainst the current court deadlines.
  3. 3
    You decide what happens nextNo cost and no obligation.
  • Built from court recordsMDL 3140 orders, JPML reports and the FDA label
  • Every answer is citedEach answer links the record it relies on
  • No invented payoutsNo settlement amount is public, so we publish none
  • Checked Nov 12, 2026Against the JPML report of Nov 2, 2026
Secure, encrypted form About 2 minutes Free review

Prefer to talk it through?

TortAdvisor is not a law firm and does not give legal advice. A trained case advisor, not an attorney, may make the first contact. See our partner list and privacy policy.

Michael Laurier-Gerard

About Michael Laurier-Gerard

Michael Laurier-Gerard Michael Laurier-Gerard is a Canadian entrepreneur, technology executive, and marketing strategist with over two decades of experience in digital marketing, technology, and product development. He is the President & CEO of UAR Global Holdings and the Founder of its sister company, BOOM! Media Group, a full-service digital marketing agency specializing in web design, SEO, and AI-driven marketing automation. Early in his career, Michael served as a Product and Marketing Advisor to eBay under the guidance of Jordan Sweetnam, Chief Commercial Officer, working with the company’s Global Markets, Payments, and Product teams. Between 2001 and 2007, he also advised startups and established companies, including CraveTV, FullScript (then Healthwave), Rogers, AT&T, and the Government of Canada, helping them scale products, optimize marketing strategies, and refine operational workflows. He is the Chief Marketing Officer at Waypoint Software, where he partners with the company to provide marketing and infrastructure solutions for a variety of co-owned products and assets. Additionally, he is the Co-Founder, SVP & Chief Technology Officer of Tort Advisor and Legal Lawsuit, leading technology strategy, platform development, and automation initiatives across both ventures. Michael combines technical expertise with strategic vision, developing platforms and marketing systems engineered for performance, scalability, and measurable outcomes. Through UAR Global Holdings, he manages multiple ventures that integrate design, analytics, and technology, positioning each company at the forefront of digital innovation. Based in Ottawa, Canada, he continues to lead initiatives that unify marketing, technology, and automation to create high-performing digital ecosystems for businesses across industries.